Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other Non Operating Income: 2010-2025

Historic Other Non Operating Income for Arrowhead Pharmaceuticals (ARWR) over the last 13 years, with Sep 2025 value amounting to $4.7 million.

  • Arrowhead Pharmaceuticals' Other Non Operating Income rose 249.33% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 400.86%. This contributed to the annual value of $5.3 million for FY2025, which is 400.86% up from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Other Non Operating Income of $4.7 million as of Q3 2025, which was up 2,745.45% from -$176,000 recorded in Q2 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Other Non Operating Income peaked at $4.7 million during Q3 2025, and registered a low of -$3.1 million during Q3 2024.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Other Non Operating Income value was $341,000 (recorded in 2024), while the average stood at $412,909.
  • Over the last 5 years, Arrowhead Pharmaceuticals' Other Non Operating Income had its largest YoY gain of 2,262.50% in 2024, and its largest YoY loss of 534.87% in 2024.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Other Non Operating Income (Quarterly) stood at -$707,000 in 2021, then soared by 171.71% to $507,000 in 2022, then decreased by 16.96% to $421,000 in 2023, then declined by 19.00% to $341,000 in 2024, then skyrocketed by 249.33% to $4.7 million in 2025.
  • Its Other Non Operating Income was $4.7 million in Q3 2025, compared to -$176,000 in Q2 2025 and $438,000 in Q1 2025.